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The clinical diagnosis of pulmonary embolism is highly
nonspecific because none of the symptoms or signs of
pulmonary embolism is unique and all may be caused
by other cardiorespiratory disorders. Thus, objective
testing is mandatory to either confirm or exclude a di-
agnosis of pulmonary embolism. Based on current avail-
able information, a diagnostic approach for the man-
agement of clinically suspected pulmonary embolism is
proposed. After a history and physical examination,
electrocardiogram and chest X-ray film, all patients should
undergo perfusion lung scanning. The finding of a nor-
mal perfusion lung scan rules out clinically significant
pulmonary embolism, and anticoagulant therapy is with·
held.
The management of patients with an abnormal per-
fusion lung scan is more complex. If this scan demon-
strates one or more segmental (or greater) perfusion
defects, ventilation lung scanning should be performed
because the probability of pulmonary embolism is mark-
edly increased if a mismatch is found, with a high prob-
ability scan (positive predictive value 86%) providing an
end point for commencing anticoagulant therapy in the
majority of patients. In an abnormal ventilation-
perfusion study, the presence of a ventilation-perfusion
match does not rule out the possibility of pulmonary
embolism, and further objective testing is required in
The clinical diagnosis of pulmonary embolism is highly
nonspecific (1-7) because none of the symptoms or signs
of pulmonary embolism is unique and all may be caused
by other cardiorespiratory disorders. A number of studies
(1-7) have shown that more than 50% of all patients with
clinically suspected pulmonary embolism have this disorder
excluded by objective testing. Thus, objective testing is
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these patients with nonhigh probability scans. Similarly,
in patients with small perfusion defects (one or more
subsegmental defects) or indeterminate lung scan find-
ings (in which the perfusion scan defects correspond to
a defect on a chest X-ray film), the predictive values
obtained from these ventilation-perfusion scan patterns
are not sufficiently high or low to confirm or exclude the
presence of pulmonary embolism.
Alternative approaches are available that would re-
duce the need for pulmonary angiography in patients
with abnormal but nonhigh probability ventilation-
perfusion lung scans. In these patients, venography or
impedance plethysmography could be performed as the
next step of the diagnostic evaluation. If the presence of
deep vein thrombosis is confirmed by these tests, anti-
coagulant therapy can be commenced without the need
to perform pulmonary angiography. If the tests are neg-
ative, pulmonary angiography is required to confirm the
presence or absence of pulmonary embolism because a
negative venogram occurs in up to 30% of patients with
pulmonary embolism by angiography and, therefore,
may not be used to exclude venous thromboembolism.
Other approaches (for example, serial impedance pleth-
ysmography) are being explored in selected patients.
(J Am Coli Cardiol1986;8:128B-136B)
mandatory to either confirm or exclude a diagnosis of pul-
monary embolism. Arterial blood gas measurements are
equally nonspecific and should not be used for diagnostic
purposes in patients with suspected pulmonary embolism
(5,6,8). A normal arterial partial pressure of oxygen (Poz)
(>80 mm Hg) does not exclude pulmonary embolism, and
abnormal blood gases occur in a wide variety of respiratory
disorders.
The radiologic abnormalities associated with pulmonary
embolism are nonspecific and occur in many other pul-
monary disorders. In addition, patients with pulmonary em-
bolism may have a normal chest radiograph at presentation.
The chest radiograph is helpful, however, in demonstrating
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other causes for the patient's condition (for example, pneu-
mothorax) and is important in interpreting the lung scan
findings.
The electrocardiogram may be useful for differentiating
between pulmonary embolism and myocardial infarction. It
is frequently normal or shows nonspecific changes, and the
classical findings associated with pulmonary embolism (right
axis shift and SlQ3T3 pattern) are uncommon and also non-
specific.
Lung scanning is extremely useful for excluding a di-
agnosis of pulmonary embolism, and when there is a large
ventilation-perfusion mismatch, lung scanning can usually
be used to confirm pulmonary embolism. Other findings by
lung scanning do not have sufficiently high or low predictive
power to either confirm or exclude pulmonary embolism
and, therefore, further investigations are required. These
include objective tests for venous thrombosis (because most
pulmonary emboli are associated with deep vein thrombosis
of the leg) and pulmonary angiography. Although there is
some morbidity associated with the use of the invasive tests
(pulmonary angiography and venography), there is virtually
none associated with noninvasive testing. Furthermore, the
morbidity from unnecessary anticoagulant therapy and in-
appropriate hospitalization exceeds that caused by pulmo-
nary angiography and venography, and these tests should
be used when other approaches are inconclusive.
Clinical Diagnosis of Pulmonary Embolism
Clinical features. Pulmonary embolism presents in a
variety of ways depending on the size and location of the
involved artery, the number of emboli and the underlying
condition of the patient. Most pulmonary emboli are clin-
ically silent. When clinical manifestations occur, the patient
can present in a number of ways. These are: I) transient
dyspnea and tachypnea with no other associated clinical
manifestations; 2) the syndrome of pulmonary infarction or
congestive atelectasis (also known as ischemic pneumonitis
or incomplete infarction), which includes pleuritic chest
pain, cough, hemoptysis, pleural effusion and pulmonary
infiltrates on chest X-ray study; 3) right-sided heart failure
associated with severe dyspnea and tachypnea; 4) cardio-
vascular collapse with hypotension, syncope and coma; and
5) various less common and less specific clinical features
including confusion, pyrexia, wheezing, resistant heart fail-
ure and unexplained arrhythmias.
The syndromes of acute right heart failure and cardio-
vascular collapse are caused by major pulmonary emboli or
multiple small emboli that obstruct more than 60% of the
pulmonary vasculature, while the clinical syndromes oftran-
sient dyspnea and pulmonary infarction may be caused by
either large or small pulmonary emboli. Most small pul-
monary emboli produce no clinical manifestations unless
multiple emboli occur, if the patient has an already com-
promised cardiorespiratory system or the embolus obstructs
a peripheral pulmonary vessel and produces pulmonary in-
farction or congestive atelectasis.
Dyspnea and tachypnea. Dyspnea is the most fre-
quently reported symptom in patients with pulmonary em-
bolism, occurring in 60 to 80% of patients with clinical
manifestations who have a major pulmonary embolism
(1,2,5,9).
Pain. Two types of chest pain occur in patients with
pulmonary embolism. The most common and characteristic
is the pleuritic pain caused by inflammation of the pleura
overlying areas of pulmonary infarction or congestive ate-
lectasis. Pulmonary infarction is usually caused by obstruc-
tion of relatively small-sized pulmonary branches which, if
obstructed acutely, behave as end arteries. Obstruction of
larger more proximal vessels is usually not associated with
pulmonary infarction because sufficient blood flow is pro-
vided through the bronchial circulation. However, a prox-
imal embolus in a large or medium-sized vessel may frag-
ment, obstruct smaller vessels and lead to pulmonary infarction
many hours or even days after the acute pulmonary embolic
event. If this occurs while the patient is being treated, it
may be incorrectly attributed to recurrent pulmonary em-
bolism.
Pleuritic pain is typically sudden in onset an aggravated
by breathing. The pain may be referred to the shoulder tip
or the anterior abdominal wall where it may be confused
with an acute abdominal emergency. It may remain localized
to a small area of the chest wall or may gradually spread
from its original location. It is likely that the onset of pleu-
ritic pain occurs hours or even days after the acute embolic
event, reflecting the time taken for pleural inflammation to
develop.
The second type of chest pain. which is less common, is
a central substernal chest pain. which may be ihdistin-
guishable from angina pectoris. This pain, which is usually
described as aching or compressing, occasionally occurs in
patients with massive pulmonary embolism. It is usually of
brief duration, lasting not more than an hour or two. The
cause of the pain is uncertain.
Hemoptysis. Although often considered to be one of the
hallmarks of pulmonary embolism, hemoptysis is actually
a relatively infrequent feature of this condition (1,2,5,9).
Its presence indicates that pulmonary infarction or conges-
tive atelectasis has occurred and produced alveolar hem-
orrhage. Hemoptysis may occur in association with pleurisy
or as an isolated event. Like pleurisy, it usually begins hours
or even days after the initial embolic event. The type of
bleeding ranges from blood-streaked sputum to frank blood
clots and very rarely to marked hemorrhage. Hemoptysis
may also be aggravated by anticoagulant therapy, but this
rarely produces a significant clinical problem.
Syncope. Syncope may occasionally be the first and
most prominent manifestation of pulmonary embolism. It
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Table 1. Differential Diagnosis of the Clinical Features of
Pulmonary Embolism
to mucous plugging or bronchoconstriction and acute pul-
monary edema. The chest X-ray film is usually nonspecific,
but may be helpful because, when it is normal, it excludes
a number of conditions, or it may be diagnostic of pneu-
mothorax or pulmonary edema.
Pleuritic chest pain. This may be a prominent feature
of musculoskeletal abnormalities of the chest wall, including
fractured ribs, myositis, muscle strain and, occasionally, of
acute pericarditis. The clinical diagnosis may be confused
with pulmonary embolism if rib fracture or intercostal mus-
cle strain complicates episodes of coughing in patients with
acute bronchitis. The presence of a pleural friction rub is
an important sign because it excludes a number of condi-
tions. The differential diagnosis of pleuritic chest pain as-
sociated with pulmonary infiltrate on chest X-ray study in-
cludes pneumonia, acute chest infection complicating
bronchiectasis or chronic bronchitis. pulmonary neoplasm,
systemic lupus erythematosus and subdiaphragmatic infec-
tion.
Hemoptysis. The differential diagnosis of hemoptysis
includes bronchitis, bronchogenic carcinoma, tuberculosis,
mitral stenosis, bronchial adenoma and bronchiectasis.
Acute right heart failure. If acute right heart failure
complicates pulmonary embolism, it is almost always as-
sociated with severe dyspnea and tachypnea. These features
can also be caused by acute pulmonary hypertension, which
complicates left ventricular failure or myocardial infarction
(large, recurrent or complicated by ventricular septal de-
fect), mitral stenosis, acute infection in patients with severe
is usually associated with massive pulmonary embolism and
is caused by reduction in cardiac output which, in tum,
results in hypotension and transient impairment of cerebral
blood flow. Submassive pulmonary embolism may occa-
sionally produce syncope due to induced cardiac tachyar-
rythmias.
Physical signs of pulmonary embolism. These are non-
specific and varied and may not be reliable indicators of the
severity of the pulmonary vascular obstruction. Although
70 to 80% of patients with pulmonary embolism have dem-
onstrated leg vein thrombosis by venography at the time of
clinical presentation (2). these thrombi are usually asymp-
tomatic. and less than 20% of patients with pulmonary em-
bolism have clinical evidence of venous thrombosis (2,9).
Massive pulmonary embolism is associated with tachy-
pnea, tachycardia, cyanosis and altered mental and con-
scious states. The patient may be hypotensive or there may
be evidence of pulsus paradoxus. The jugular venous pres-
sure is elevated, often with a prominent A wave, which may
sometimes be difficult to appreciate by clinical examination.
Cardiac examination may be nonspecific and often reveals
a prominent right ventricular impulse, a loud pulmonary
component of the second heart sound and gallop rhythm.
Frequently, there is a systolic murmur, which may either
be ejection or pansystolic in type. Physical examination of
the chest may be normal or reveal nonspecific abnormalities.
Rarely is there evidence of airway obstruction.
The physical findings in patients with submassive pul-
monary embolism may be limited to tachypnea and tachy-
cardia or there may be associated cardiac or respiratory
manifestations of massive embolism.
Patients with pulmonary infarction or congestive atelec-
tasis have reduced movement of the affected portion of the
chest. There may be signs of pulmonary consolidation or
atelectasis, a pleural friction rub, rales or pleural effusion.
Fever occurs irrespective of the presence or absence of pul-
monary infarction; when present, it is usually mild «101°F).
Very rarely, the temperature may rise to over 103°F and be
associated with rigors.
Differential Diagnosis of the Clinical
Manifestations of Pulmonary Embolism
(Table 1)
Shortness of breath is a common manifestation of anxiety
and a number of cardiac and respiratory conditions that may
be difficult to differentiate from pulmonary embolism, par-
ticularly when it occurs in a clinical setting (for example.
postoperatively) in which pulmonary embolism might be
suspected. The differential diagnosis of shortness of breath
includes atelectasis, pneumothorax, pneumonia, acute bron-
chitis, acute bronchiolitis, acute bronchial obstruction due
Dyspnea
AtelectaSIs
Pneumonia
Pneumothorax
Acute pulmonary edema
Acute bronchItis
Acute bronchIOlitis
Acute bronchial obstructIon
(asthma)
HyperventilatIOn
Metabolic acidosis
Pleuritic chest pam
Pneumonia
Pneumothorax
Pericarditis
Pulmonary neoplasm
BronchiectaSIs
SubdiaphragmatIc inflammatIOn
Myositis
Muscle strain
RIb fracture
Hemoptysis
Pneumonia
Bronchial neoplasm
Bronchiectasis
Acute bronchitis
Mitral stenosis
Tuberculosis
Acute right heart failure
Myocardial mfarction
Myocarditis
Cardiac tamponade
Acute respiratory infection
complicating chronic lung
disease
Cardiovascular collapse
Myocardial mfarction
Acute masSIve hemorrhage
Gram negative septicemia
Cardiac tamponade
Spontaneous pneumothorax
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chronic obstructive lung disease or pulmonary embolism of
nonthrombotic origin.
Patients with chronic obstructive lung disease may de-
velop acute pulmonary hypertension, severe dyspnea and
right heart failure when their course is complicated by acute
chest infection. In some patients, the acute exacerbation is
caused by occult infection, bronchiolitis, bronchial irritation
by noxious materials or depression of the respiratory center
by sedatives. Minor pulmonary embolism may produce acute
respiratory failure in patients with chronic obstructive lung
disease. Finally, cardiac tamponade, myocarditis or right
ventricular infarction should also be considered in the dif-
ferential diagnosis of acute right heart failure.
Cardiovascular collapse. Patients with massive pul-
monary embolism may present with acute hypotension,
tachycardia, peripheral and central cyanosis, confusion and
coma. The conditions that may be confused with massive
embolism include myocardial infarction complicated by car-
diogenic shock, acute pericardial tamponade, acute massive
blood loss and gram negative septicemia. Differentiation
between acute massive pulmonary embolism and myocardial
infarction with complicating cardiogenic shock can usually
be made by findings on electrocardiography and echocardi-
ography and by measurement of specific myocardial enzyme
levels in the serum.
Patients with acute pericardial tamponade may present
with peripheral circulatory failure and engorged neck veins.
Chest pain may be a prominent feature if acute pericardial
tamponade has complicated dissection of the ascending aorta
or myocardial infarction. Occasionally, dyspnea may be
absent, and the diagnosis of aortic dissection may be sus-
pected by finding unequal pulses or marked differences in
blood pressure between limbs. Definitive differentiation,
however, requires echocardiography or angiocardiography.
Occasionally, massive blood loss may be confused with
acute major pulmonary embolism, particularly if it occurs
postoperatively or in a patient with venous thromboembol-
ism who is being treated with anticoagulants. Measurement
of the venous pressure provides a useful means of differ-
entiating between the two conditions. The patient with blood
loss responds clinically to volume expansion with either
blood or other intravenous fluids, and the hematocrit is
usually decreased when compared with the level obtained
before the episode of hypotension even though it does not
reflect the total amount of blood lost.
Patients with gram negative septicemia may develop car-
diovascular collapse, which can simulate acute major pul-
monary embolism. If severe acidemia is present, dyspnea
may occur and be a prominent feature. Confusion is most
likely to arise in the postoperative patient who is also at
high risk for developing major pulmonary embolism. Al-
though the two conditions can usually be differentiated after
a number of hours, it may be extremely difficult to do so
soon after presentation.
Diagnostic Tests for Pulmonary Embolism
Pulmonary Angiography
Pulmonary angiography is the accepted diagnostic ref-
erence standard for establishing the presence or absence of
pulmonary embolism (10-12). In recent years, the diag-
nostic accuracy of pulmonary angiography has been mark-
edly improved and the risk reduced by using selective an-
giography and magnification views (10-16). A diagnosis of
pulmonary embolism is made if there is a constant intra-
luminal filling defect seen on multiple films or if sharp
cutoffs can be seen in vessels greater than 2.5 mm in di-
ameter, which are constant in multiple films. Other abnor-
malities such as oligemia, vessel pruning and loss of filling
of small vessels are nonspecific and may occur in pneu-
monia, atelectasis, bronchiectasis, postinflammatory atro-
phy, primary pulmonary hypertension, pulmonary venous
hypertension, emphysema and pulmonary carcinoma. Loss
of filling may also occur for technical reasons, but this
artifact can often be avoided by careful attention to technique
with repeated injection of small volumes of dye (for ex-
ample, 20 cc).
Risks and complications. Both hypotension and ar-
rhythmias resulting in death have been observed in patients
undergoing main pulmonary outflow dye injection. These
risks can be reduced by using selective pulmonary angi-
ography with repeated injections of small volumes of dye.
Specifically, selective pulmonary angiography is a safe tech-
nique in the absence of severe chronic pulmonary hyper-
tension or severe cardiac or respiratory decompensation
(2,9,15). Nevertheless, although the risk of pulmonary an-
giography has been substantially reduced in recent years by
the use of the selective technique, its invasive nature and
the associated risks contraindicate its use in a significant
number of very ill patients whose clinical course has been
complicated by suspected pulmonary embolism. In our ex-
perience (2,9), approximately 20% of patients with clini-
cally suspected pulmonary embolism and abnormal perfu-
sion lung scan findings cannot undergo pulmonary
angiography because of the severity of their primary illness.
Overall, clinically significant complications including
tachyarrhythmias, endocardial or myocardial injury, cardiac
perforation, cardiac arrest and hypersensitivity reactions to
contrast medium occur in up to 3 to 4% of patients undergo-
ing pulmonary angiography (15). Patients with a history of
allergy to radiopague dye should not have pulmonary an-
giography performed.
Significance of a negative test. One retrospective long-
term follow-up study (16) has been performed to validate
the negative predictive value of a negative pulmonary an-
giogram. Although none of the patients with a negative
pulmonary angiogram developed thromboembolic compli-
cations during follow-up, this study was flawed because
13% of the patients with a negative pulmonary angiogram
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were lost to follow-up. The use of a negative pulmonary
angiogram to rule out pulmonary embolism has been crit-
icized because angiography may have insufficient sensitivity
to detect small emboli that can be detected by perfusion
lung scanning (10). Therefore, additional follow-up studies
are required to evaluate the clinical significance of a negative
pulmonary angiogram in patients with clinically suspected
pulmonary embolism.
Because of the limitations of pulmonary angiography,
extensive efforts have been made to replace this invasive
technique with less invasive diagnostic tests (2-9, 17-23).
The early studies with less invasive tests (serum lactate
dehydrogenase and arterial gases) were inadequately de-
signed, and the diagnostic recommendations drawn from
these studies were spurious. A falsely high specificity for
the diagnosis of pulmonary embolism was attributed to per-
fusion lung scanning, which was subsequently refuted by
multiple studies (1-7,9,17-21). The uncritical acceptance
of many of these diagnostic tests for pulmonary embolism
has resulted in inappropriate and potentially dangerous treat-
ment in many patients.
Perfusion Lung Scanning
The history of perfusion lung scanning dates back to the
early 1960s (24). Rapid improvements in instrumentation
(with the development of the gamma camera) and radi-
opharmaceuticals (with the development of technetium-
99m-labeled macroaggregated albumin) led to rapid ac-
ceptance of the perfusion lung scan for the investigation of
pulmonary embolism.
Identification of perfusion defects. Perfusion lung
scanning can detect regions of poor perfusion as small as 2
cm in diameter. However, an abnormal perfusion scan is
nonspecific (1-7,9,17-21) and cannot identify the cause of
the perfusion defect because disturbances in pulmonary blood
flow from any cause produce an abnormal scan. In patients
with suspected pulmonary embolism, the majority of lung
scan defects are produced by conditions other than pul-
monary embolism. In these patients, perfusion defects are
usually secondary to ventilation abnormalities caused by
disorders with regional hypoxia and consequent hypoxic
pulmonary vasoconstriction or to loss of the vascular bed
such as occurs in emphysema.
The poor specificity of perfusion lung scanning for the
diagnosis of pulmonary embolism has been demonstrated
in a number of studies (2-4,9).
This has been confirmed in a recent prospective study
(2,9) of 305 consecutive patients with clinically suspected
pulmonary embolism and abnormal perfusion lung scan
findings. The presence of pulmonary embolism by angi-
ography was demonstrated in only 95 (52%) of 183 patients
with abnormal perfusion lung scans and adequate pulmonary
angiographic results. In all of these studies, exclusion from
the analysis of patients who had abnormal chest X-ray find-
ings did not overcome the problems of the nonspecificity
of the abnormal lung scan findings.
Accuracy of perfusion scanning. Attempts were made
to improve the specificity of the perfusion scan by classi-
fying the defects according to size and number, but the
probabilities obtained were unacceptable for making indi-
vidual patient decisions (3,4). For example, in a recent study
(2,9), pulmonary angiography confirmed the presence of
pulmonary embolism in only 65 (71 %) of 90 patients with
one or more segmental or greater perfusion defects, 25 (37%)
of 68 patients with one or more subsegmental perfusion
defects and 5 (21 %) of 24 patients in whom the lung scan
defect corresponded to the defect on chest X-ray study.
Ventilation-Perfusion Lung Scanning
Ventilation lung scanning is performed using either ra-
dioactive gases or radioactive aerosols that are inhaled and
exhaled by the patient while a gamma camera records the
distribution of radioactivity within the alveolar gas exhange
units. Ventilation imaging was introduced into clinical prac-
tice for the diagnosis of pulmonary embolism on the premise
that ventilation is perserved in areas of reduced perfusion
due to pulmonary embolism (ventilation-perfusion mis-
match), whereas ventilation is abnormal when perfusion
defects result from the physiologic response to primary pa-
renchymal disease (ventilation-perfusion match) (17,22).
Thus, it was assumed that the addition of ventilation imaging
would improve the specificity of an abnormal perfusion lung
scan by differentiating embolic occlusion of the pulmonary
vasculature from perfusion defects occurring secondary to
a primary disorder of ventilation. The basic premise that
perfusion defects that ventilate normally are due to pul-
monary embolism, whereas matching ventilation-perfusion
abnormalities are caused by other conditions was not sup-
ported by early studies in experimental animals (25,26), and
was recently shown to be incorrect on the basis of findings
in a prospective clinical trial (2,9).
Ventilation lung scanning with radioactive gases. Much
of the current understanding of the physiology of regional
pulmonary ventilation is based on studies performed with
the radioactive gases such as xenon-133 or xenon-127
(3,4,17-19). There are practical problems with the use of
radioactive xenon in clinical practice (20,21). With all ra-
dioactive xenons, the ventilation technique requires the pa-
tient to rebreathe the gas from a closed circuit spirometer
or bag system. The complexity of the technique limits the
imaging to only one view. With xenon-133, the ventilation
image is traditionally performed from the posterior view
before the technetium-99m-macroaggregated albumin per-
fusion scan because the technetium-99 gamma rays degrade
the xenon-133 images. With this approach, the ventilation
image may not be obtained from the view that best dem-
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onstrates the perfusion defect. Another potential problem in
the interpretation of ventilation-perfusion scans is that the
spatial resolution with xenon-133 is inferior to the resolution
obtained with technetium-99m. As a consequence, small
defects in perfusion may appear to ventilate well with xenon-
133 when, in fact, the region is poorly ventilated but too
small to be resolved with this radionuclide.
Several approaches have been taken to improve the ven-
tilation images with different radioactive gases such as
xenon-l27 and krypton-81m. With the former, the venti-
lation image can be obtained after the perfusion lung scan
from whichever view best demonstrates the lesion, but the
technical difficulties inherent in the xenon ventilation tech-
nique still apply. For those institutions within easy reach of
a cyclotron, krypton-81 m has the potential to be a superior
agent. Its spatial resolution is comparable with that of tech-
netium-99m, and multiple views of the lungs are routinely
obtained (20). The expense and lack of availability of kryp-
ton-81 m and the inadequacies of radioactive xenons have
prompted investigation into the use of other agents for mea-
suring regional ventilation and led to the recent major in-
terest in the use of radioactive aerosols (20,21).
Radioaerosol ventilation imaging. When inhaled into
the lungs, submicronic aerosols lodge mainly in peripheral
airways and have a distribution pattern essentially the same
as that of radioactive xenons and krypton-81m. The advent
of inexpensive disposable aerosol systems to nebulize tech-
netium-99m radiopharmaceuticals has made aerosol venti-
lation scans available to all nuclear medicine departments.
The use of technetium-99m-Iabeled aerosols (either tech-
netium-99m-DTPA or technetium-99m-sulfur colloid) have
advantages in terms of image resolution and availability
(20). In addition, once deposited in the lung, the aerosol
remains for at least I hour, permitting multiple views of the
lungs to be obtained.
match (in an area that is normal on chest roentgenogram)
virtually rules out the possibility of pulmonary embolism
(3).
3) Mismatch with perfusion defects is (virtually) diagnostic
of acute embolism, and the main role for pulmonary
angiography is in patients with a nondiagnostic scan (27).
Basis for Diagnostic Approaches to
Pulmonary Embolism
Retrospective studies and nonconsecutive patient se-
ries. The published data (3,4, 17-22) supporting the clinical
application of ventilation-perfusion lung scanning were, un-
til recently, taken largely from retrospective studies or from
nonconsecutive prospective patient series. The initial studies
(17,22), which included only small numbers of patients,
reported a falsely high degree of efficacy for ventilation-
perfusion lung scanning. The results of subsequent larger
retrospective surveys (3,4) reported false positive rates for
ventilation-perfusion mismatches of 20% and 48%, respec-
tively.
Attempts were made to improve the specificity of ven-
tilation-perfusion lung scanning by classifying the perfusion
defects according to their size and number and the presence
of matched or mismatched ventilation defects (3,4, 18). Mul-
tiple large defects with normal ventilation were reported to
be associated with a very high probability of pulmonary
embolism, while other lung scan patterns were reported to
be associated with a lower frequency of pulmonary embo-
lism, leading to the concept of "low probability" patterns.
However, the concept that a "low probability" lung scan
pattern can be used to rule out pulmonary embolism has
been challenged by the findings from prospective studies
(2,9).
Prospective consecutive patient series (Table 2). In a
recent study, (2,9), a consecutive series of patients with
clinically suspected pulmonary embolism and an abnormal
Reproduced with permission from Hull RD, et
al (9).
Table 2. Frequency of Pulmonary
Embolism Associated With the Individual
Ventilation-Perfusion Scan Patterns
Diagnostic Approaches to Suspected
Pulmonary Embolism Using
Ventilation-Perfusion Lung Scanning
A number of diagnostic approaches have been recom-
mended for patients with clinically suspected pulmonary
embolism. These approaches, which are contradictory, are
based on the following concepts:
I) Ventilation scans are only occasionally helpful, and pul-
monary angiography is the most accurate diagnostic means
currently available (10).
2) Ventilation-perfusion mismatch correlates to a high de-
gree with pulmonary embolism in patients undergoing
angiography (3), and in individual patients, the venti-
lation-perfusion patterns can be assigned estimates of
probability on which decisions concerning management
can be based. The presence of a ventilation-perfusion
VenlllatlOn-Perfusion
Scan Pattern
One or more segmental
or greater defects
MH,match
Match
One or more subsegmental
defects
Mismatch
Match
Indeterminate
Frequency of
Pulmonary Embolism
51 of 59 (86%)
10 of 28 (36%)
16 of 40 (40%)
6 of 24 (25%)
5 of 24 (21%)
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*Reproduced wIth permission from Hull RD, et al.
(2,9).
Figure 1. Diagnostic algorithm for management of suspected pul-
monary embolism (PE). IPa = impedance plethysmography;
V-Q = ventilation-perfusIOn.
Table 3. Frequency of Proximal Vein
Thrombosis (PROX-DVT) Detected by
Impedance Plethysmography Associated
With the Individual Ventilation-Perfusion
Scan Patterns
?
!
IPG
NEGATIVE
Frequency of
PROX·DVT
6 of 40 (15%)
4 of 24 (17%)
5 of 24 (21%)
I of 95 (1%)
29 of 59 (49%)
7 of 28 (25%)
1
v-a Scan
NON·HIGH PROBABILITY
!
Treat
IPG
POSITIVE
Treat
!
v-a Scan
HIGH-PROBABILITY
Clinically Suspected
pUlmOna,) Embolism
v·a Lung Scan
1
VentilatlOn-Perfusion
Scan Pattern
One or more segmental
or greater defects
MIsmatch
Match
One or more subsegmental
defects
Mismatch
Match
Indeterminate
Normal
!
v-a Scan
NORMAL
PE Excluded
diagnostic end point for pulmonary embolism, and is of
doubtful validity since more than 50% of patients with an
abnormal perfusion lung scan do not have pulmonary em-
bolism confirmed by pulmonary angiography (1-4,6,18-21).
In a recent prospective study (2), deep vein thrombosis by
venography was present in 70% of patients with pulmonary
embolism documented by pulmonary angiography. The
demonstration of silent venous thrombosis in patients with
clinically suspected pulmonary embolism is clinically very
useful since in most cases, the treatment of deep vein throm-
bosis and pulmonary embolism is the same.
Role of impedance plethysmography. The results of
impedance plethysmography were compared with the ven-
The Role of Objective Testing
for Venous Thrombosis in the Diagnostic
Evaluation of Patients With Suspected
Pulmonary Embolism
It has been demonstrated in postmortem studies (28) that
most patients with pulmonary embolism have deep vein
thrombosis of the legs. These autopsy findings, however,
may not reflect the relation between venous thrombosis and
pulmonary embolism in the living patient.
Role of venography. Recently, the association between
deep vein thrombosis and pulmonary embolism has been
examined in patients with clinically suspected pulmonary
embolism (2,9,29). Some of the earlier studies reported that
up to 50% of patients with pulmonary embolism did not
have detectable deep vein thrombosis. This impression was
based on the use of an abnormal perfusion lung scan as the
perfusion lung scan were entered prospectively in a protocol
requiring ventilation-perfusion lung scanning, pulmonary
angiography and venography in all patients (unless these
tests were contraindicated because of concurrent life-threat-
ening cardiac or respiratory illness). The results of venti-
lation-perfusion lung scanning, therefore, did not influence
the decision to perform pulmonary angiography and ven-
ography. Bias due to diagnostic suspicion (in which knowl-
edge of one test finding might influence the interpretation
of another) was avoided by interpreting all of the test find-
ings independently and without knowledge of each other or
the patient's clinical status. Patients with large perfusion
defects (one or more segmental or greater defects) and ven-
tilation mismatch have a high probability of pulmonary em-
bolism; 51 (86%) of 59 patients in this category had pul-
monary embolism by angiography (Table 2). This observation
is consistent with findings previously reported (3,4,17-20).
However, the frequency of pulmonary embolism was not
sufficiently low to rule out pulmonary embolism in patients
with either a large ventilation-perfusion match or in those
with small perfusion defects. In the latter patients (with one
or more subsegmental defects), pulmonary angiography
confirmed the presence of pulmonary embolism in 16 (40%)
of 40 patients with ventilation mismatch and in 6 (25%) of
24 patients with ventilation match.
These findings indicate that the strategy of using a "low
probability" lung scan pattern to rule against pulmonary
embolism is incorrect. The observed frequencies of pul-
monary embolism associated with those lung scan patterns,
which have been traditionally regarded as "low probabil-
ity," ranged from 25 to 40% (2,9). The use of an improved
method of ventilation scanning (technetium-99m aerosol
ventilation imaging) that provided excellent ventilation im-
aging did not improve the specificity of ventilation-perfusion
lung scan abnormalities.
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ographic findings in these patients with clinically suspected
pulmonary embolism, Even though most of the proximal
vein thrombi were silent, almost 90% were detected by
impedance plethysmography, and a positive result was highly
predictive of venous thromboembolism (a positive predic-
tive value of greater than 95%) (2,9). Patients presenting
with clinically suspected pulmonary embolism with lung
scan patterns that have been traditionally regarded as "low
probability" had a substantial frequency of extensive deep
vein thrombosis (Table 3), The presence of proximal vein
thrombosis in these patients has important management im-
plications because recent randomized clinical trials (30-32)
have shown that failure to treat proximal deep vein throm-
bosis is associated with a high risk of recurrent venous
thromboembolism,
Significance of a negative test. Although most patients
with pulmonary embolism shown by pulmonary angiogra-
phy had deep vein thrombosis by venography, the frequency
of a negative venogram associated with pulmonary embo-
lism by pulmonary angiography was 30% (2), Patients with
negative findings by venography but with pulmonary em-
bolism shown by angiography may have had their source
of embolism in the deep pelvic veins, renal veins, inferior
vena cava or right atrium. Alternatively, the pulmonary
emboli may have been derived from the deep veins of the
legs, but all or most of the thrombi embolized, leaving no
residual thrombi detectable by venography. Thus, although
a positive result by venography or impedance plethysmog-
raphy can be used as the basis for commencing therapy, a
negative result cannot be used to exclude venous throm-
boembolism (2,9).
Suggested Diagnostic Strategy for Clinically
Suspected Pulmonary Embolism
A diagnostic algorithm for the management of clinically
suspected pulmonary embolism is shown in Figure I. After
a history and physical examination, electrocardiogram and
chest X-ray study, all patients should undergo perfusion lung
scanning. The finding of a normal perfusion lung scan rules
out clinically significant pulmonary embolism, and anti-
coagulant therapy is withheld.
Patients with an abnormal perfusion lung scan. The
management of these patients is more complex. If the per-
fusion lung scan demonstrates one or more segmental (or
greater) perfusion defects, ventilation lung scanning should
be performed because the probability of pulmonary embo-
lism is markedly increased if a mismatch is found (positive
predictive value 86%); this high probability scan provides
an end point for commencing anticoagulant therapy in the
majority of patients. The presence of a ventilation-perfusion
match does not rule out the possibility of pulmonary em-
bolism, and further objective testing is required in these
patients. Similarly, in patients with small perfusion defects
(one or more subsegmental defects) or indeterminate lung
scan findings (in which the perfusion scan defect corre-
sponds to a defect on the chest X-ray film), the predictive
values obtained from these ventilation-perfusion scan pat-
terns are neither sufficiently high nor low to confirm or
exclude the presence of pulmonary embolism.
Alternative approaches to reduce the need for angi-
ography. Alternative approaches are available that would
reduce the need for pulmonary angiography in patients with
abnormal but nonhigh probability ventilation-perfusion lung
scans, In these patients, venography or impedance pleth-
ysmography could be performed as the next step of the
diagnostic process. If the presence of deep vein thrombosis
is confirmed by these tests, anticoagulant therapy can be
commenced without performing pulmonary angiography. If
the tests are negative, pulmonary angiography is required
to confirm the presence or absence of pulmonary embolism
because a negative venogram occurs in up to 30% of patients
with pulmonary embolism by angiography and, therefore,
may not be used to exclude venous thromboembolism.
An alternative strategy that we are currently exploring in
patients with good cardiorespiratory reserve and "low prob-
ability" or indeterminate lung scans and negative impedance
plethysmography at presentation is to use surveillance with
serial impedance plethysmography to detect recurrent or
extending venous thrombosis. The rationale for this ap-
proach is based on the premise that clinically significant
recurrent pulmonary embolism is very unlikely in patients
who do not have proximal vein thrombosis, and that serial
impedance plethysmography can be used to detect extending
deep vein thrombosis (33,34). Serial impedance plethys-
mography has been used successfully to detect clinically
important venous thrombosis in patients with clinically sus-
pected deep vein thrombosis whose venogram is negative
at presentation (35) and, therefore, holds promise in patients
with suspected pulmonary embolism who are stable clini-
cally. This approach is likely to be more successful than
venography alone because in patients with negative veno-
graphic findings at presentation, the putative thrombus may
have embolized completely, but in the absence of further
testing, could reccur undetected and lead to serious recurrent
pulmonary embolism. Furthermore, because of its invasive
nature, venography cannot be readily repeated.
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